Biovance

About Biovance

Biovance is a European biotechnology-focused investment firm that backs disruptive, early-stage biopharma companies across Europe. The firm collaborates with entrepreneurs to build leading biotech entities, typically investing in seed and Series A rounds and bringing additional investors to add value and reduce risk. Biovance emphasizes supporting development of transformative therapies across all modalities and therapeutic areas, partnering with portfolio companies to bring novel treatments to patients in need. The firm maintains a broad European network including research institutes, incubators, and accelerators to access a strong pipeline of potential investments.